首页> 外文期刊>Case Reports in Genetics >Previously Unreported Chromosomal Aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a Patient with Accelerated Phase Ph+ CML
【24h】

Previously Unreported Chromosomal Aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a Patient with Accelerated Phase Ph+ CML

机译:Ph + CML加速期患者中t(3; 3)(q29; q23),t(4; 11)(q21; q23)和t(11; 18)(q10; q10)的以前未报告的染色体畸变

获取原文
       

摘要

Chronic myelogenous leukemia (CML) is a clonal hematological disorder, which is characterized by the presence of the classical or variant Philadelphia translocations. During the progression to blastic phase of the disease secondary chromosomal abnormalities may emerge. Such secondary chromosomal abnormalities are nonrandom, the more frequent ones being trisomy 8 and 19, supernumerary i(17q), and extra Philadelphia chromosomes. Furthermore, a minor percentage of the patients may acquire different secondary chromosomal abnormalities including translocations between other chromosomes. We report here a patient with Ph+ CML presenting secondary chromosomal abnormalities including t(4;11)(q21;q23), t(3;3)(q29;q23) and t(11;18)(q10;q10) during the course of CML progression.
机译:慢性粒细胞性白血病(CML)是一种克隆性血液病,其特征是存在费城经典或变种易位。在疾病发展为成骨期期间,可能会出现继发性染色体异常。这样的继发性染色体异常是非随机的,更常见的是8三体和19三体,多余的i(17q)和多余的费城染色体。此外,一小部分患者可能会获得不同的继发性染色体异常,包括其他染色体之间的易位。我们在此报告的Ph + CML患者在继发期间出现t(4; 11)(q21; q23),t(3; 3)(q29; q23)和t(11; 18)(q10; q10)的继发性染色体异常CML进展过程。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号